US 8455454
miR 204, miR 211, their anti-miRs, and therapeutic uses of same
granted A61KA61K31/7105A61P
Quick answer
US patent 8455454 (miR 204, miR 211, their anti-miRs, and therapeutic uses of same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7105, A61P, A61P27/02, A61P27/10